Therapeutic Innovation
Advancing medicine through breakthrough therapeutic solutions across multiple disease areas
Our Therapeutic Focus Areas
Oracle BioTech develops innovative therapies across a broad range of therapeutic areas, addressing unmet medical needs with cutting-edge science and patient-focused solutions.
Gene & Cell Therapy
Revolutionary approaches to treating genetic disorders through advanced gene editing and cellular reprogramming technologies.
- CRISPR-based gene editing platforms
- CAR-T cell immunotherapies
- Stem cell regenerative medicine
- Gene delivery systems
Oncology
Comprehensive cancer treatment solutions targeting multiple pathways and tumor types with precision medicine approaches.
- Targeted small molecule inhibitors
- Monoclonal antibody therapies
- Combination treatment strategies
- Biomarker-driven personalized medicine
Central Nervous System
Novel treatments for neurological and psychiatric disorders using advanced understanding of brain biology and neural pathways.
- Neurodegenerative disease modifiers
- Blood-brain barrier delivery systems
- Neuroprotective compounds
- Psychiatric disorder treatments
Development Pipeline
Discovery
12 ProgramsTarget identification and validation using cutting-edge screening technologies and computational approaches.
Preclinical
8 ProgramsLead optimization, safety studies, and IND-enabling activities preparing for human trials.
Phase I
5 ProgramsFirst-in-human studies evaluating safety, tolerability, and preliminary efficacy signals.
Phase II
3 ProgramsProof-of-concept studies demonstrating efficacy in target patient populations.
Phase III
2 ProgramsPivotal registration-enabling studies comparing to standard of care treatments.